Inovio closes $173M public stock sale to fund Covid-19 vaccine development
January 26, 2021 at 10:35 AM EST
The company is conducting mid-stage testing of a Covid-19 vaccine candidate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|